DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Weycker D, Li X, Barron R. et al.
Importance of risk factors for febrile neutropenia among patients receiving chemotherapy regimens not classified as high-risk in guidelines for myeloid growth factor use.
J Natl Compr Canc Netw 2015;
13: 979-986.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.